399 results
8-K
EX-3.1
DMKPQ
DMK Pharmaceuticals Corp
23 Jan 24
Material Modifications to Rights of Security Holders
5:22pm
”).
Section 5. Annual Meetings.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election of directors … , for any purpose or purposes, by (i) the Chairman of the Board of Directors, (ii) the President or Chief Executive Officer, (iii) the Board
8-K
EX-10.3
cvf2o
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.4
ywwg78sj xlxs
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.1
ska2x
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.2
t2a142ks z2ml
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
PX14A6G
0p1o mr0qf9n93fvhg
17 Oct 23
Letter to shareholders
12:28pm
DEFC14A
m527vpprp 40r4ascl3j
12 Oct 23
Proxy in contested solicitation
4:22pm
PREC14A
gqtcpu6
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
8-K
EX-3.2
yhtj fcxjgd
8 Sep 23
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
4:50pm
8-K
EX-10.1
gbfdj5r ivvc2vc
29 Aug 23
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
psyd4 05q
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
8-K
EX-1.1
yx3fh8
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
424B4
y92sghcb
3 Aug 23
Prospectus supplement with pricing info
4:55pm
8-K
EX-10.2
9f0ee80
24 Jul 23
Entry into a Material Definitive Agreement
4:20pm